ETC
Exchange Traded Concepts’s Recursion Pharmaceuticals RXRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-18,624
| Closed | -$98.5K | – | 1474 |
|
|
2025
Q1 | $98.5K | Sell |
18,624
-32,137
| -63% | -$170K | ﹤0.01% | 1163 |
|
|
2024
Q4 | $343K | Buy |
50,761
+25,579
| +102% | +$173K | 0.01% | 828 |
|
|
2024
Q3 | $166K | Buy |
25,182
+5,021
| +25% | +$33.1K | ﹤0.01% | 1016 |
|
|
2024
Q2 | $151K | Sell |
20,161
-6,271
| -24% | -$47K | ﹤0.01% | 905 |
|
|
2024
Q1 | $264K | Buy |
26,432
+10,073
| +62% | +$100K | 0.01% | 846 |
|
|
2023
Q4 | $161K | Buy |
16,359
+4,148
| +34% | +$40.9K | ﹤0.01% | 820 |
|
|
2023
Q3 | $93.4K | Sell |
12,211
-2,089
| -15% | -$16K | ﹤0.01% | 921 |
|
|
2023
Q2 | $107K | Buy |
+14,300
| New | +$107K | ﹤0.01% | 934 |
|